Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes

Neal A Halsey, Leonard B. Weiner, Martin G. Meyers, Kenneth L. Herrmann, Alan Hinman

Research output: Contribution to journalArticle

Abstract

A new measles vaccine (CAM) prepared in chick chorioallantoic membranes was compared with the routinely used measles vaccine (Attenuvax, Merck, Sharpe and Dohme) prepared in chick embryo tissue culture for immunogenicity and adverse reactions in 77 children. Recipients of the CAM vaccine developed significantly (P = 0·001) higher hemagglutination-inhibition (HI) geometric mean antibody titers (83·3 v. 42·8) than did recipients of Attenuvax. CAM vaccine recipients also experienced significantly (P <0·01) higher rates of fever and rash in the period 6-15 days after vaccination. Although the CAM vaccine was more immunogenic than Attenuvax, the higher rates of fever and rash make the vaccine unacceptable for routine primary vaccination of children.

Original languageEnglish (US)
Pages (from-to)507-511
Number of pages5
JournalJournal of Biological Standardization
Volume9
Issue number4
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Measles Vaccine
Chorioallantoic Membrane
Vaccines
Computer aided manufacturing
Membranes
Exanthema
Vaccination
Fever
Tissue culture
Hemagglutination
Chick Embryo
Antibodies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes. / Halsey, Neal A; Weiner, Leonard B.; Meyers, Martin G.; Herrmann, Kenneth L.; Hinman, Alan.

In: Journal of Biological Standardization, Vol. 9, No. 4, 1981, p. 507-511.

Research output: Contribution to journalArticle

Halsey, Neal A ; Weiner, Leonard B. ; Meyers, Martin G. ; Herrmann, Kenneth L. ; Hinman, Alan. / Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes. In: Journal of Biological Standardization. 1981 ; Vol. 9, No. 4. pp. 507-511.
@article{cc8fd61654c94604b66a967c6e76dcb0,
title = "Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes",
abstract = "A new measles vaccine (CAM) prepared in chick chorioallantoic membranes was compared with the routinely used measles vaccine (Attenuvax, Merck, Sharpe and Dohme) prepared in chick embryo tissue culture for immunogenicity and adverse reactions in 77 children. Recipients of the CAM vaccine developed significantly (P = 0·001) higher hemagglutination-inhibition (HI) geometric mean antibody titers (83·3 v. 42·8) than did recipients of Attenuvax. CAM vaccine recipients also experienced significantly (P <0·01) higher rates of fever and rash in the period 6-15 days after vaccination. Although the CAM vaccine was more immunogenic than Attenuvax, the higher rates of fever and rash make the vaccine unacceptable for routine primary vaccination of children.",
author = "Halsey, {Neal A} and Weiner, {Leonard B.} and Meyers, {Martin G.} and Herrmann, {Kenneth L.} and Alan Hinman",
year = "1981",
doi = "10.1016/S0092-1157(81)80043-1",
language = "English (US)",
volume = "9",
pages = "507--511",
journal = "Biologicals",
issn = "1045-1056",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes

AU - Halsey, Neal A

AU - Weiner, Leonard B.

AU - Meyers, Martin G.

AU - Herrmann, Kenneth L.

AU - Hinman, Alan

PY - 1981

Y1 - 1981

N2 - A new measles vaccine (CAM) prepared in chick chorioallantoic membranes was compared with the routinely used measles vaccine (Attenuvax, Merck, Sharpe and Dohme) prepared in chick embryo tissue culture for immunogenicity and adverse reactions in 77 children. Recipients of the CAM vaccine developed significantly (P = 0·001) higher hemagglutination-inhibition (HI) geometric mean antibody titers (83·3 v. 42·8) than did recipients of Attenuvax. CAM vaccine recipients also experienced significantly (P <0·01) higher rates of fever and rash in the period 6-15 days after vaccination. Although the CAM vaccine was more immunogenic than Attenuvax, the higher rates of fever and rash make the vaccine unacceptable for routine primary vaccination of children.

AB - A new measles vaccine (CAM) prepared in chick chorioallantoic membranes was compared with the routinely used measles vaccine (Attenuvax, Merck, Sharpe and Dohme) prepared in chick embryo tissue culture for immunogenicity and adverse reactions in 77 children. Recipients of the CAM vaccine developed significantly (P = 0·001) higher hemagglutination-inhibition (HI) geometric mean antibody titers (83·3 v. 42·8) than did recipients of Attenuvax. CAM vaccine recipients also experienced significantly (P <0·01) higher rates of fever and rash in the period 6-15 days after vaccination. Although the CAM vaccine was more immunogenic than Attenuvax, the higher rates of fever and rash make the vaccine unacceptable for routine primary vaccination of children.

UR - http://www.scopus.com/inward/record.url?scp=0019865453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019865453&partnerID=8YFLogxK

U2 - 10.1016/S0092-1157(81)80043-1

DO - 10.1016/S0092-1157(81)80043-1

M3 - Article

C2 - 7033226

AN - SCOPUS:0019865453

VL - 9

SP - 507

EP - 511

JO - Biologicals

JF - Biologicals

SN - 1045-1056

IS - 4

ER -